TVTX vs VOO
Travere Therapeutics Inc (TVTX) versus VOO (VOO) — a side-by-side from cached financials, not a winner call.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
VOO (VOO) common stock.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
VOO does not have a complete income-statement cache yet.
TVTX currently screens at market cap $1.33B. VOO currently screens at market cap $0.
Not investment advice. Open the TVTX and VOO stock pages for the full models.
Not investment advice.